Biotech Values

[DewDiligence]

Chinese drug companies have problems with “suspect” clinical data:

http://health.economictimes.indiatimes.com/news/pharma/china-rejects-11-drug-applications-over-inadequate-trial-data/49763450

China has signalled a tougher stance on drug quality in the country's sprawling pharmaceuticals industry by rejecting applications for 11 medicines with inadequate or suspect clinical data.

The China Food and Drug Administration (CFDA) said in statement posted on its website on Nov. 11 that the move affected eight Chinese companies making generic drugs for heart problems, schizophrenia, pain, infections and other diseases.

A positive for multinational drugmakers who sell products in China.